Cargando…
Long-term treatment with metformin in the prevention of fatty liver in Zucker diabetic fatty rats
BACKGROUND: Treatment with metformin, the biguanide of hepatic insulin sensitizer, in patients with non-alcoholic fatty liver disease (NAFLD) has been reported with contradictory findings regarding the effectiveness on blood lipids and liver histology. In this study, we aimed to explore the preventi...
Autores principales: | Sui, Yi, Kong, Xianhe, Fan, Rongrong, Ye, Yanbin, Mai, Haiyan, Zhuo, Shuyu, Lu, Wei, Ruan, Peishan, Fang, Shi, Yang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852932/ https://www.ncbi.nlm.nih.gov/pubmed/31749893 http://dx.doi.org/10.1186/s13098-019-0491-1 |
Ejemplares similares
-
Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats
por: Zhang, Minchun, et al.
Publicado: (2019) -
Effect of Metformin Treatment on Serum Metabolic Profile Changes in Lean and Obese Zucker Rat Model for Fatty Liver Disease
por: Melnyk, Stepan, et al.
Publicado: (2023) -
Urinary Metabolomic Profiling in Zucker Diabetic Fatty Rats with Type 2 Diabetes Mellitus Treated with Glimepiride, Metformin, and Their Combination
por: Dong, Yu, et al.
Publicado: (2016) -
Coenzyme A and Its Thioester Pools in Obese Zucker and Zucker Diabetic Fatty Rats
por: Chohnan, Shigeru, et al.
Publicado: (2020) -
Lipopolysaccharides accelerate hepatic steatosis in the development of nonalcoholic fatty liver disease in Zucker rats
por: Fukunishi, Shinya, et al.
Publicado: (2014)